53本のエピソード
BJUI - BJU International BJUI - BJU International
-
- 科学
BJUI aims to provide the very highest standard of research and clinical information for the urological community, promoting awareness of new advances and supporting best practice in urology.
The journal publishes original articles, reviews, comments and educational articles. Clinical relevance is critical and the journal covers the entire breadth of urology under the following sections: Comments, Reviews, Urological Oncology (all areas of urological oncology as well as recent advances in diagnostic techniques), Robotics and Laparoscopy, Upper Urinary Tract, Functional Urology, Andrology, Translational Science and Professional Innovation.
BJUI is constantly innovating to provide the urology community with a journal that is fresh in appearance and easy to read.
-
BJUI/BURST: : Summary of NICE guidelines for management of lower urinary tract symptoms in men
Dr Arman Chacko presents a summary of NICE guidelines on male lower urinary tract symptoms.
Arman is in his second year of core surgical training in the Southwest Peninsula Deanery, UK, and is a member of #BURSTurology.
https://www.nice.org.uk/guidance/cg97 -
BJUI Knowledge: Professionalism
Drs Kieran O'Flynn and Steve Payne discuss professionalism in urology.
For more information, please access BJUI Knowledge:
https://bjuiknowledge.bjuinternational.com/ -
BJUI/BURST - Randomised trial of HoLEP vs ThuLEP vs bipolar enucleation of large size prostate
In this podcast Dr Sasha Vereecken describes and evaluates the randomised trial of holmium laser vs thulium laser vs bipolar enucleation of large prostate gland.
(https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.16174)
The aim of the trial is to compare the outcome and morbidity of bipolar transurethral enucleation of the prostate (B-TUEP) and thulium laser enucleation of the prostate (ThuLEP) with those of holmium laser enucleation of the prostate (HoLEP) in the treatment of large symptomatic benign prostatic obstruction (BPO) through a non-inferiority randomised controlled trial (NCT03916536). -
BJUI/BURST: NICE guidance on UTIs in patients aged 16 and over
Miss Srushti Bhat (@dr_srushti) is a Urology-themed CT2 in the East Midlands and a BURST member. Here she discusses updates to the NICE guidance on diagnosis and management of UTIs in patients aged 16 and over.
https://www.nice.org.uk/guidance/qs90/chapter/Quality-statements -
BJUI/BURST: Radiological features characterising indeterminate testes masses
In this podcast from BJUI and BURST urology Dr Eunice Ter Zuling discusses the 2022 paper "Radiological features characterising indeterminate testes masses: a systematic review and meta-analysis" (https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.15869)
-
BJUI/BURST: Second-line treatment options for erectile dysfunction
Mr Rammah Mohammed Ali Abdlbagi, a Urology SHO at Northampton General Hospital in the UK, discusses second-line treatment options for erectile dysfunction based on the BJUI Knowledge module and NICE's clinical summary.
He is part of BURST urology.
https://bjuiknowledge-portal.bjuinternational.com/#/catalogue/landingpage/item/74bd70f4-7648-4318-a5c2-07b173eb0e7b/
https://cks.nice.org.uk/topics/erectile-dysfunction/#!backgroundsub:1